Scarlet Therapeutics

Scarlet Therapeutics Demonstrates In Vivo Survival of Lab-Grown Universal Red Blood Cells Equivalent to Donated Blood

£3.2M Seed Round Closed to Accelerate Platform Development 7 May 2026 — Bristol, UK — Scarlet Therapeutics today announces a landmark preclinical result: its proprietary cell-line derived, universal, lab-grown red blood cells (“RBCs”) have successfully matured and circulated in vivo, achieving a half-life comparable to normal donated red blood cells. Critically, Scarlet’s RBCs are designed…
Science Creates Old Market Midland Rd Bristol BS2 0JZ United Kingdom